Mario Guralnik
Plus aucun poste en cours
Historique de carrière de Mario Guralnik
Anciens postes connus de Mario Guralnik
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ora Bio Ltd.
Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Corporate Officer/Principal | 04/03/2010 | - |
AMGEN INC. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Mario Guralnik
University of California, Los Angeles | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Israël | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMGEN INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Ora Bio Ltd.
Ora Bio Ltd. Pharmaceuticals: MajorHealth Technology Ora Bio Ltd. engaged in the repositioning of existing drugs for second-use applications. The firm develops its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration. The company was founded by Yossi Israeli and Amichai Baron in June 2005 and is headquartered in Nazareth Illit, Isreal. | Health Technology |
- Bourse
- Insiders
- Mario Guralnik
- Expérience